Standard BioTools Gross Margin 2011-2025 | LAB
Current and historical gross margin for Standard BioTools (LAB) over the last 10 years. The current gross profit margin for Standard BioTools as of September 30, 2025 is %.
| Standard BioTools Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.17B | $0.08B | 46.71% |
| 2025-06-30 | $0.17B | $0.08B | 47.93% |
| 2025-03-31 | $0.17B | $0.08B | 47.34% |
| 2024-12-31 | $0.17B | $0.08B | 48.28% |
| 2024-09-30 | $0.12B | $0.06B | 50.00% |
| 2024-06-30 | $0.12B | $0.06B | 47.93% |
| 2024-03-31 | $0.13B | $0.06B | 48.82% |
| 2023-12-31 | $0.11B | $0.05B | 47.17% |
| 2023-09-30 | $0.11B | $0.05B | 45.71% |
| 2023-06-30 | $0.11B | $0.05B | 43.40% |
| 2023-03-31 | $0.10B | $0.04B | 37.11% |
| 2022-12-31 | $0.10B | $0.04B | 36.36% |
| 2022-09-30 | $0.11B | $0.05B | 40.91% |
| 2022-06-30 | $0.11B | $0.05B | 44.25% |
| 2022-03-31 | $0.13B | $0.06B | 49.60% |
| 2021-12-31 | $0.13B | $0.07B | 52.67% |
| 2021-09-30 | $0.14B | $0.08B | 54.35% |
| 2021-06-30 | $0.15B | $0.09B | 57.72% |
| 2021-03-31 | $0.14B | $0.09B | 59.03% |
| 2020-12-31 | $0.14B | $0.08B | 58.99% |
| 2020-09-30 | $0.13B | $0.07B | 58.73% |
| 2020-06-30 | $0.11B | $0.06B | 56.25% |
| 2020-03-31 | $0.11B | $0.06B | 55.26% |
| 2019-12-31 | $0.12B | $0.06B | 55.17% |
| 2019-09-30 | $0.12B | $0.07B | 56.03% |
| 2019-06-30 | $0.12B | $0.07B | 56.30% |
| 2019-03-31 | $0.12B | $0.07B | 56.41% |
| 2018-12-31 | $0.11B | $0.06B | 55.36% |
| 2018-09-30 | $0.11B | $0.06B | 52.78% |
| 2018-06-30 | $0.10B | $0.05B | 50.96% |
| 2018-03-31 | $0.10B | $0.05B | 50.00% |
| 2017-12-31 | $0.10B | $0.05B | 50.49% |
| 2017-09-30 | $0.10B | $0.05B | 52.00% |
| 2017-06-30 | $0.10B | $0.05B | 53.61% |
| 2017-03-31 | $0.10B | $0.06B | 55.45% |
| 2016-12-31 | $0.10B | $0.06B | 56.73% |
| 2016-09-30 | $0.11B | $0.06B | 57.27% |
| 2016-06-30 | $0.12B | $0.07B | 58.12% |
| 2016-03-31 | $0.12B | $0.07B | 58.47% |
| 2015-12-31 | $0.12B | $0.07B | 58.62% |
| 2015-09-30 | $0.12B | $0.07B | 60.17% |
| 2015-06-30 | $0.12B | $0.07B | 60.50% |
| 2015-03-31 | $0.12B | $0.07B | 61.86% |
| 2014-12-31 | $0.12B | $0.07B | 63.25% |
| 2014-09-30 | $0.11B | $0.07B | 64.76% |
| 2014-06-30 | $0.09B | $0.06B | 67.74% |
| 2014-03-31 | $0.08B | $0.06B | 70.73% |
| 2013-12-31 | $0.07B | $0.05B | 71.83% |
| 2013-09-30 | $0.07B | $0.05B | 71.21% |
| 2013-06-30 | $0.06B | $0.04B | 70.49% |
| 2013-03-31 | $0.06B | $0.04B | 68.42% |
| 2012-12-31 | $0.05B | $0.04B | 67.92% |
| 2012-09-30 | $0.05B | $0.03B | 68.00% |
| 2012-06-30 | $0.05B | $0.03B | 66.67% |
| 2012-03-31 | $0.05B | $0.03B | 67.39% |
| 2011-12-31 | $0.04B | $0.03B | 68.18% |
| 2011-09-30 | $0.04B | $0.03B | 68.29% |
| 2011-06-30 | $0.04B | $0.03B | 71.05% |
| 2011-03-31 | $0.04B | $0.02B | 68.57% |
| 2010-12-31 | $0.03B | $0.02B | 66.67% |
| 2010-06-30 | $0.02B | $0.01B | 55.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.558B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.700B | 42.44 |
| Tempus AI (TEM) | United States | $12.562B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.471B | 68.91 |
| Doximity (DOCS) | United States | $8.256B | 33.99 |
| IRhythm Technologies (IRTC) | United States | $5.440B | 0.00 |
| Hinge Health (HNGE) | United States | $3.912B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.797B | 62.83 |
| Privia Health (PRVA) | United States | $3.064B | 191.62 |
| Heartflow (HTFL) | United States | $2.255B | 0.00 |
| Omnicell (OMCL) | United States | $1.968B | 40.24 |
| 10x Genomics (TXG) | United States | $1.957B | 0.00 |
| Azenta (AZTA) | United States | $1.623B | 66.60 |
| Enovis (ENOV) | United States | $1.514B | 7.95 |
| Clover Health Investments (CLOV) | United States | $1.395B | 0.00 |
| Schrodinger (SDGR) | United States | $1.330B | 0.00 |
| Phreesia (PHR) | United States | $0.980B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.839B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.760B | 0.00 |
| Claritev (CTEV) | United States | $0.619B | 0.00 |
| CapsoVision (CV) | United States | $0.602B | 0.00 |
| Talkspace (TALK) | United States | $0.581B | 117.00 |
| Veradigm (MDRX) | United States | $0.539B | 0.00 |
| Evolent Health (EVH) | United States | $0.460B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.413B | 0.00 |
| Carlsmed (CARL) | United States | $0.344B | 0.00 |
| TruBridge (TBRG) | United States | $0.338B | 15.55 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.321B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.280B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.268B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.157B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.149B | 0.00 |
| CareCloud (CCLD) | United States | $0.139B | 7.65 |
| Pulmonx (LUNG) | United States | $0.104B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.087B | 0.00 |
| HeartBeam (BEAT) | United States | $0.079B | 0.00 |
| Outset Medical (OM) | United States | $0.076B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.066B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.044B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.037B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |